Evidence map›Paper›PMID 42020764›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2026

Model-based analysis of stop-signal data reveals robust neural and clinical correlates of evidence accumulation but not inhibition.

Yihe Weng, Rory Boyle, Chi Tak Lee, Declan Quinn, Clodagh Earley, Maike Splittgerber, Lili Zhang, Luisa Franzen, Tobias Banaschewski, Arun L W Bokde and 23 more

Abstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Yihe WengSchool of Psychology and Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.ORCID http://orcid.org/0009-0005-2628-9492
Rory BoyleSchool of Psychology and Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.
Chi Tak LeeSchool of Psychology and Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.
Declan QuinnSchool of Psychology and Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.
Clodagh EarleySchool of Psychology and Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.
Maike SplittgerberSchool of Psychology and Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.
Lili ZhangSchool of Computing, Dublin City University, Dublin, Ireland.
Luisa FranzenSchool of Psychology and Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.
Tobias BanaschewskiDepartment of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, 68159, Mannheim, Germany.ORCID http://orcid.org/0000-0003-4595-1144
Arun L W BokdeDiscipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.ORCID http://orcid.org/0000-0003-0114-4914
Sylvane DesrivièresSocial, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.ORCID http://orcid.org/0000-0002-9120-7060
Herta FlorInstitute of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, Mannheim, Germany.ORCID http://orcid.org/0000-0003-4809-5398
Antoine GrigisNeuroSpin, CEA, Université Paris-Saclay, F-91191, Gif-sur-Yvette, France.
Hugh GaravanDepartments of Psychiatry and Psychology, University of Vermont, 05405, Burlington, Vermont, USA.ORCID http://orcid.org/0000-0002-8939-1014
Penny GowlandSir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, UK.ORCID http://orcid.org/0000-0002-4900-4817
Andreas HeinzDepartment of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.
Rüdiger BrühlPhysikalisch-Technische Bundesanstalt (PTB), Braunschweig and Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0003-0111-5996
Jean-Luc MartinotINSERM U1299 "Developmental Trajectories in Psychiatry & Addictology"; University Paris-Saclay, Ecole Normale Supérieure Paris-Saclay, Mathematics department, Centre Borelli CNRS UMR9010, Gif-sur-Yvette, France.ORCID http://orcid.org/0000-0002-0136-0388
Marie-Laure Paillère MartinotINSERM U1299 "Developmental Trajectories in Psychiatry & Addictology"; University Paris-Saclay, Ecole Normale Supérieure Paris-Saclay, Mathematics department, Centre Borelli CNRS UMR9010, Gif-sur-Yvette, France.
Eric ArtigesINSERM U1299 "Developmental Trajectories in Psychiatry & Addictology"; University Paris-Saclay, Ecole Normale Supérieure Paris-Saclay, Mathematics department, Centre Borelli CNRS UMR9010, Gif-sur-Yvette, France.ORCID http://orcid.org/0000-0003-4461-7646
Jane McGrathDiscipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.
Frauke NeesInstitute of Medical Psychology, Ludwig-Maximilians-Universität (LMU) in Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-7796-8234
Dimitri Papadopoulos OrfanosDepartment of Psychology, School of Social Sciences, University of Mannheim, 68131, Mannheim, Germany.ORCID http://orcid.org/0000-0002-1242-8990
Luise PoustkaDepartment of Child and Adolescent Psychiatry, Center for Psychosocial Medicine, , University Hospital Heidelberg, Heidelberg, Germany.
Nathalie HolzDepartment of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, 68159, Mannheim, Germany.ORCID http://orcid.org/0000-0002-6225-9267
Sarah HohmannDepartment of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, 68159, Mannheim, Germany.
Michael N SmolkaDepartment of Psychiatry and Psychotherapy, Technische Universität Dresden, Dresden, Germany.ORCID http://orcid.org/0000-0001-5398-5569
Nilakshi VaidyaCentre for Population Neuroscience and Stratified Medicine (PONS), Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Berlin, Germany.
Gunter SchumannCentre for Population Neuroscience and Stratified Medicine (PONS), Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0002-7740-6469
Henrik WalterDepartment of Psychiatry and Psychotherapy CCM, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.ORCID http://orcid.org/0000-0002-9403-6121
Alexander Weigard *Department of Psychiatry and Addiction Center, University of Michigan, 4250 Plymouth Rd, Ann Arbor, MI, 48109, USA.ORCID http://orcid.org/0000-0003-3820-6461
Robert Whelan *School of Psychology and Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland. Robert.Whelan@tcd.ie.ORCID http://orcid.org/0000-0002-2790-7281
IMAGEN Consortium

Funding

Training U54EB020403 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMPSON, PAUL M · 2014 to 2018
$10.1M
A decentralized macro and micro gene-by-environment interaction analysis of substance use behavior and its brain biomarkers R01DA049238 · NIDA · GEORGIA STATE UNIVERSITY · PI CALHOUN, VINCE D, LIU, JINGYU · 2019 to 2023
$2.9M
Axon, Testosterone and Mental Health during AdolescenceR01MH085772 · NIMH · BAYCREST CENTRE FOR GERIATRIC CARE · PI PAUS, TOMAS · 2010 to 2014
$1.5M
Leveraging computational models of neurocognition to improve predictions about individual youths' risk for substance use disordersK23DA051561 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WEIGARD, ALEXANDER · 2021 to 2025
$983k
ENIGMA World Aging CenterR56AG058854 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMPSON, PAUL M · 2018 to 2018
$683k
Agence Nationale de la Recherche (French National Research Agency) AAPG2019 - GeBraAgence Nationale de la Recherche (French National Research Agency) ANR-12-SAMA-0004NIA NIH HHS R56 AG058854NIBIB NIH HHS U54 EB020403NIDA NIH HHS K23 DA051561NIDA NIH HHS R01 DA049238NIMH NIH HHS R01 MH085772Science Foundation Ireland (SFI) 16/ERCD/3797
6 · The paper itself

Abstract

Poor inhibitory control and decision-making are often considered as risks for substance use and other adverse psychiatric outcomes. The Stop-Signal Task (SST) is a widely used protocol, from which inhibitory control is indexed by stop signal reaction time (SSRT). However, heretofore models of SSRT may be too simplistic to capture complex processes underlying task performance. In contrast, the Racing Diffusion Ex-Gaussian ABCD (RDEX-ABCD) model provides a more mechanistic framework, capturing both inhibitory control and task-general decision-making processes during the SST. Here, we applied the RDEX-ABCD model to SST data from the IMAGEN cohort (n > 1000) at ages 19 and 23, and examined model parameters in relation to substance use via Elastic Net regression. Connectome-based predictive modeling was then performed to identify brain networks predicting parameters, and the association between these networks and substance use was examined. We found that parameters indexing inhibitory control had no associations with substance use and were only weakly associated with brain connectivity. In contrast, parameters reflecting general decision-making processes - such as efficiency of evidence accumulation, decision threshold (response caution), probability of go failure - and their associated brain activity were significant predictors of cannabis and cigarette use. These findings suggested that efficiency of evidence accumulation, a neurocognitive mechanism that facilitates adaptive decision making across many contexts, emerged as a robust predictor of substance use vulnerability. Overall, general decision-making mechanisms may act as more reliable indicators of vulnerability to substance use than the conventional inhibitory control measures.

Identifiers

PMID42020764
PMCPMC13592875

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.